The opposite trends observed for the serum Trx1 levels between CAP and the other investigated diseases support the utility of Trx1 as a diagnostic marker for CAP over Hp because serum Hp levels are significantly elevated in both patients with CAP and those with lung cancer. Here, HP is linked to lung cancer.